Management of hypertriglyceridemia-induced acute pancreatitis involves supportive care and specific therapies like plasmapheresis and insulin, though direct comparative studies are currently lacking.
What is the optimal management strategy for hypertriglyceridemia-induced acute pancreatitis?
This review provides a comprehensive summary of treatment approaches for hypertriglyceridemia-induced acute pancreatitis, including acute triglyceride-lowering therapies and long-term management.
Hypertriglyceridemia is an uncommon but a well-established etiology of acute pancreatitis leading to significant morbidity and mortality. The risk and severity of acute pancreatitis increase with increasing levels of serum triglycerides. It is crucial to identify hypertriglyceridemia as the cause of pancreatitis and initiate appropriate treatment plan. Initial supportive treatment is similar to management of other causes of acute pancreatitis with additional specific therapies tailored to lower serum triglycerides levels. This includes plasmapheresis, insulin, heparin infusion, and hemofiltration. After the acute episode, diet and lifestyle modifications along with hypolipidemic drugs should be initiated to prevent further episodes. Currently, there is paucity of studies directly comparing different modalities. This article provides a comprehensive review of management of hypertriglyceridemia induced acute pancreatitis. We conclude by summarizing our treatment approach to manage hypertriglyceridemia induced acute pancreatitis.
Garg et al. (Thu,) conducted a review in Hypertriglyceridemia induced acute pancreatitis. Management strategies (plasmapheresis, insulin, heparin, hemofiltration) was evaluated. Management of hypertriglyceridemia-induced acute pancreatitis involves supportive care and specific therapies like plasmapheresis and insulin, though direct comparative studies are currently lacking.